Esperion Therapeutics Inc (0ET.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR

Add to watchlist

2.1390

+0.2280

(+11.93%)

As of 08:02AM CEST. Market open.

Loading interactive chart…

GuruFocus.com
Esperion Therapeutics Inc (ESPR) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues ...
Discover how Esperion Therapeutics achieved a historic revenue milestone and expanded market potential in its first quarter of 2024.
GuruFocus.com
Esperion Therapeutics Inc (ESPR) Surpasses Q1 Revenue Forecasts with a 467% Increase
Significant Growth and FDA Approvals Propel Performance
Zacks
Esperion Therapeutics (ESPR) Q1 Earnings and Revenues Beat Estimates
Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of 525% and 159.32%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?